[Skip to Navigation]
Comment & Response
October 2017

PCSK9 Inhibitors, Statins, Low-Density Lipoprotein Cholesterol, Mevalonate Pathway, and Toxicity

Author Affiliations
  • 1Internal Medicine Unit, University Hospital Alcorcon Foundation, Rey Juan Carlos University, Madrid, Spain
JAMA Cardiol. 2017;2(10):1168-1169. doi:10.1001/jamacardio.2017.2727
Add or change institution
×